Tumor Biology Overview

Principles

Definition

Tumor biology is the academic field dedicated to investigating the fundamental biological and molecular mechanisms underlying tumor formation, growth, and metastasis. This research provides the essential foundation for understanding cancer progression and developing diagnostic and therapeutic strategies.

Ontological type

Metastatic Cascade

Tumor Microenvironment

Tumor Initiation Mechanisms

Key developments

Key Figures

Histogenetic Metastasis Paradigm era

César Milstein [1], associated with the University of Cambridge [3] and the University of Oxford [4] in this era, made foundational advances in diagnostic and experimental immunology. His 1975 paper Continuous cultures of fused cells secreting antibody of predefined specificity [7] introduced continuous cultures of fused cells secreting antibodies of predefined specificity, underpinning hybridoma technology and enabling standardized antibody production that anchored experimental models in diagnostic practice. Isaiah J. Fidler [2], with affiliations at the University of Pennsylvania [5] and the University of California, Irvine [6], helped shape this era's thinking about metastasis. His 1973 paper Selection of Successive Tumour Lines for Metastasis [8] and his 1970 paper Metastasis: Quantitative Analysis of Distribution and Fate of Tumor Emboli Labeled With 125I-5-Iodo-2′-deoxyuridine [9] provided the empirical framework for selecting tumor lines and quantifying metastatic spread, advancing histogenetic metastasis paradigms by linking tumor morphology, lineage classification, and metastatic routes.

Molecular Signaling Networks era

Bert Vogelstein [1], associated with Harvard University [3] and the Massachusetts Institute of Technology [4], epitomizes the era. His key contributions include recognizing that p53 mutations occur across diverse human tumour types [7], and clarifying β-Catenin-Tcf signaling in colon cancer through Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC [5] and Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon Carcinoma [6], which illuminated how signaling networks govern proliferation and genomic stability. Eric S. Lander [2], associated with Harvard University [3] and the Massachusetts Institute of Technology [4], is a central figure in shaping the era's networks through gene expression mapping. His key contribution is Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring [8], which bridged gene expression profiling with the integrated network view of oncogenic signaling in cancer.

Tumor Microenvironment and Immunity era

Ahmedin Jemal[1], associated with Harvard University[3] and the University of Pennsylvania[4] in this era, is a leading cancer epidemiologist shaping global perspectives on tumor biology. His contributions span the Global cancer statistics 2011[8] and Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[7], which synthesize worldwide incidence and mortality patterns and establish benchmarks essential for prioritizing research and informing immuno-oncology strategies in diverse tumor contexts. Freddie Bray[2], affiliated with Albert Einstein College of Medicine[5] and Heidelberg University[6], is a co-author on the Global cancer statistics 2011[8] and Global cancer statistics 2018[7] papers. His epidemiological synthesis provides foundational context for cross-cancer comparisons and supports resource prioritization and biomarker-driven therapy development within the tumor microenvironment and immunity paradigm.